Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
Midsummer is considered prime beach season, but investors know that, more importantly, it's second-quarter earnings season.
With that in mind, this episode of The Motley Fool's Market Checkup is dedicated to the world's largest health-care conglomerate, Johnson & Johnson (NYSE: JNJ ) . Watch and find out how the second-quarter results of Big Pharma stocks stack up, and what challenges and opportunities lie ahead for for each of its business segments.
In this video, health-care analysts David Williamson and Max Macaluso drill down on Johnson and Johnson's fastest-growing division: pharmaceuticals. Watch and find out why, after a few sleepy years, this division is showing robust growth on key product launches, including whether the company's strong performance can continue into the future.
Taking a break from the volatile biotech sector? Looking for ways to diversify into dividend-paying stocks? The Motley Fool's special report, "Secure Your Future With 9 Rock-Solid Dividend Stocks," is a great way to kick-start your search. Just click here to get your free copy today.
Follow David on Twitter: @MotleyDavid.